Prof. Dr. Stephan Ludwig

Weitere Beteiligungen

• 28.03.2023

  • Poster
  • P 067

  Variant-specific humoral immune response in an immunocompromised patient experiencing severe, prolonged SARS-CoV-2 infection complicated by escape mutants and self-limiting Omicron re-infection

   Clinical virology
• 28.03.2023

  • Poster
  • P 068

  Detection and differentiation of variant-specific antibodies against the SARS-CoV-2 spike protein using nanoluciferase-tagged RBD- and NTD-antigens in sVNT and capture EIA

   Clinical virology
• 28.03.2023

  • Poster
  • P 234

  The host-targeted MEK1/2-inhibitor ATR-002 (Zapnometinib) acts antiviral against SARS-CoV-2 and synergistically potentiates the antiviral effect of direct-acting anti-SARS-CoV-2 drugs

   Host cell factors and modulation, SARS-CoV-2
• 28.03.2023

  • Poster
  • P 238

  A virus-free reporter enzyme assay to identify antiviral drug candidates against SARS-CoV-2 spike protein mediated cell-cell fusion

   Antiviral therapy and resistance, SARS-CoV-2
• 28.03.2023

  • Poster
  • P 036

  Insights into the antiviral activity of Hypericum perforatum extract and its ingredient hypericin

   Antiviral therapy and resistance, SARS-CoV-2
• 28.03.2023

  • Poster
  • P 186

  Interference of host anti-viral factor Nicastrin with the assembly/budding of influenza A virus

   Host cell factors and modulation, Structure, assembly, egress
• 28.03.2023

  • Poster
  • P 190

  Immunomodulatory role of cellular p38 MAP kinase in Influenza virus and Streptococcus pneumoniae super-infection

   Host cell factors and modulation, Innate immunity
• 30.03.2023

  08:45 – 09:00 12 Min. 3 Min.

  • Abstract Talk
  • O 080

  Cotreatment with Influenza inhibitors and recombinant IFNα as a potential strategy to prevent emergence of drug resistance against direct-acting antivirals

   Antiviral therapy and resistance, Innate immunity
• 31.03.2023

  11:15 – 11:30 12 Min. 3 Min.

  • Abstract Talk
  • O 105

  Molecular characterisation of a 2017/18 clinical influenza B/Yamagata isolate reveals improved adaptation to the human lower respiratory tract

   Viral pathogenesis and persistence, Viral replication strategies 1 (RNA viruses)